Validity and reliability of the Chinese (Singapore) version of the Parkinson's Disease Questionnaire (PDQ-39)

Quality of Life Research

Volumn 14, Issue 1, 2005, Pages 273-279

  Luo, N ^a   Tan, L C S ^b   Li, S C ^a   Soh, L K ^a   Thumboo, J ^a,c  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b National Neuroscience Institute   (Singapore)

^c SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Health status; Parkinson's disease; Quality of life; Reproducibility of results; Singapore

Indexed keywords

ADULT; AGED; ARTICLE; CHINESE; CONTROLLED STUDY; CORRELATION COEFFICIENT; FACTORIAL ANALYSIS; FEMALE; HUMAN; MALE; PARKINSON DISEASE; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; QUESTIONNAIRE; RELIABILITY; SINGAPORE; VALIDATION PROCESS;

ADULT; AGED; AGED, 80 AND OVER; CHINA; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 13844256318     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11136-004-2654-1     Document Type: Article

References (19)

1. Peto V, Jenkinson C, Fitzpatrick R, Greenhall R. The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease. Qual Life Res 1995; 4: 241-248.
2. Martinez-Martin P, Frades Payo B. Quality of life in Parkinson's disease: Validation study of the PDQ-39 Spanish version. The Grupo Centro for Study of Movement Disorders. J Neurol 1998; 245 (Suppl 1): 34-38.
3. Bushnell DM, Martin ML. Quality of life and Parkinson's disease: Translation and validation of the US Parkinson's Disease Questionnaire (PDQ-39). Qual Life Res 1999; 8: 345-350.
4. Katsarou Z, Bostantjopoulou S, Peto V, Alevriadou A, Kiosseoglou G. Quality of life in Parkinson's disease: Greek translation and validation of the Parkinson's disease questionnaire (PDQ-39). Qual Life Res 2001; 10: 159-163.
5. Jenkinson C, Fitzpatrick R, Peto V, Greenhall R, Hyman N. The PDQ-8: Development and validation of a short-form Parkinson's disease questionnaire. Psychol Health 1997; 12: 805-814.
6. Rabin R, de Charro F. EQ-5D: A measure of health status from the EuroQol Group. Ann Med 2001; 33: 337-343.
7. Gibb WRG, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988; 51: 745-752.
8. Jenkinson C, Fitzpatrick R, Peto V, Greenhall R, Hyman N. The Parkinson's Disease Questionnaire (PDQ-39): Development and validation of a Parkinson's disease summary index score. Age Ageing 1997; 26: 353-357.
9. Luo N, Chew LH, Fong KY, Koh DR, Ng SC, Yoon KH, Vasoo S, Li SC, Thumboo J. Validity and reliability of the EQ-5D self-reported questionnaire in Chinese-speaking patients with rheumatic diseases in Singapore. Ann Acad Med Singapore 2000; 32: 685-690.
10. Luo N, Chew LH, Fong KY, Koh DR, Ng SC, Yoon KH, Vasoo S, Li SC, Thumboo J. A comparison of the EQ-5D and the health utilities index mark 3 (HUI3) in patients with rheumatic diseases. J Rheumatol 2003; 30: 2268-2274.
11. Dolan P. Modeling valuations for EuroQol health states. Med Care 1997; 35: 1095-1108.
12. Peto V, Jenkinson C, Fitzpatrick R. PDQ-39: A review of the development, validation and application of a Parkinson's disease quality of life questionnaire and its associated measures. J Neurol 1998; 245 (Suppl 1): S10-S14.
13. Fayers PM, Machin D. Quality of Life: Assessment, Analysis and Interpretation. Chichester: John Wiley & Sons, 2000.
14. Schrag A, Selai C, Jahanshahi M, Quinn NP. The EQ-5D - a generic quality of life measure - is a useful instrument to measure quality of life in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 2000; 69: 67-73.
15. Juniper EF, Gordon HG, Roman J. How to develop and validate a new health-related quality of life instrument. In: Spilker B (ed), Quality of Life and Pharmacoeconomics in Clinical Trials. 2nd ed. Philadelphia: Lippincott-Raven Publishers, 1996: 49-56.
16. Hays RD, Anderson RT, Revicki D. Assessing reliability and validity of measurement in clinical trials. In: Staquet MJ, Hays RD, Fayers PM (eds), Quality of Life Assessment in Clinical Trials Methods and Practice. Oxford: Oxford University Press, 1998: 169-182.
17. Nunnally JC, Bernstein IR. Psychometric Theory, 3rd ed. New York: McGraw-Hill, 1994.
18. Jenkinson C, Fitzpatrick R, Norquist J, Findley L, Hughes K. Cross-cultural evaluation of the Parkinson's Disease Questionnaire: Tests of data quality, score reliability, response rate, and scaling assumptions in the United States, Canada, Japan, Italy, and Spain. J Clin Epidemiol 2003; 56: 843-847.
19. Damiano AM, McGrath MM, Willian MK, Snyder CF, LeWitt PA, Reyes PF, Richter RR, Means ED. Evaluation of a measurement strategy for Parkinson's disease: Assessing patient health-related quality of life. Qual Life Res 2000; 9: 87-100.